531689 — Mahavir Advanced Remedies Income Statement
0.000.00%
Last trade - 00:00
Consumer DefensivesMicro Cap
2010 March 31st | 2011 March 31st | 2012 March 31st | 2013 March 31st | 2014 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.92 | 2.4 | 2.08 | 1.45 | 3.2 |
Cost of Revenue | |||||
Gross Profit | 0.554 | 0.756 | — | — | — |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2.55 | 2.88 | 5.25 | 2.98 | 1.82 |
Operating Profit | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
Net Income Before Taxes | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.629 | -0.472 | -3.17 | -1.53 | 1.38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.126 | -0.094 | -0.633 | -0.135 | 0.121 |
Dividends per Share |